A researcher from Milan, Italy has discovered that neutrophils – a type of white blood cell that forms an essential part of the immune system – can help identify triggers and predictors of progression to type 1 diabetes (T1D).
Your Disability Tax Credit claim: An update
If you’re among those denied the Disability Tax Credit, you may need to reach out to the CRA.
Ontario teens develop innovative survival kit for people with diabetes
For most people, a power failure is a huge inconvenience. However, for someone living with type 1 diabetes (T1D), it can be a daunting – and potentially fatal – experience since their insulin needs to be kept refrigerated.
Essential apps for your diabetes toolbox
How do you know which app might be helpful for you?
7 Quick Tips for Drinking with Type 1 Diabetes
We sat down with our JDRF Marketing & Communications summer student, Evelyn Riddell, who lives with type 1 diabetes (T1D) to get her quick tips on how to drink responsibly with T1D.
TEDDY study offers insights into causes of early T1D
The Environmental Determinants of Diabetes in the Young (TEDDY) is following more than 7,000 at-risk children from infancy to 15 years of age to determine the causes of T1D.
Getting Real: My Experience Modelling with Type 1 Diabetes
Evelyn, our Marketing Communications Assistant for the summer, was featured in the latest bra campaign, and the T1D community is loving it!
Developing an insulin patch pump with open-protocol communication
Imagine an automated insulin delivery system that is able to connect with other devices seamlessly. A state-of-the-art, tubeless technology that provides continuous insulin therapy, operates on its own platform and publishes its own communication protocol.
New JDRF-funded study aims to prevent type 1 diabetes in infants
Researchers at Oxford University (UK) are offering powdered insulin to babies at high risk of developing type 1 diabetes (T1D) with the hope of training their immune systems to tolerate the insulin they produce, thereby offering life-long protection against the disease.
JDRF and Gubra collaborate on the advancement of a new glucose-responsive insulin for diabetes
JDRF has joined forces with Danish biotech company, Gubra, to develop a glucose-responsive insulin (GRI) as a treatment for people with insulin-dependent diabetes.
JDRF-funded research promoted at annual ADA conference
JDRF’s leadership was highlighted at the American Diabetes Association’s 78th Scientific Sessions.
Our Guide to Navigating BBQ Season
How to navigate BBQ season with type 1 diabetes.